IRIS
CONTI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.690
EU - Europa 5.427
AS - Asia 2.945
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 7
OC - Oceania 5
Totale 15.118
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.510
CN - Cina 1.822
IE - Irlanda 1.074
SG - Singapore 892
DE - Germania 856
UA - Ucraina 844
SE - Svezia 817
FI - Finlandia 775
IT - Italia 615
CA - Canada 177
TR - Turchia 166
AT - Austria 154
GB - Regno Unito 93
FR - Francia 73
BE - Belgio 43
NL - Olanda 23
IN - India 21
CZ - Repubblica Ceca 15
ES - Italia 14
JP - Giappone 13
EU - Europa 12
CI - Costa d'Avorio 9
EG - Egitto 8
IL - Israele 7
BR - Brasile 6
ID - Indonesia 6
BJ - Benin 5
LT - Lituania 5
RO - Romania 5
ZA - Sudafrica 5
RU - Federazione Russa 4
HK - Hong Kong 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PL - Polonia 3
AU - Australia 2
EE - Estonia 2
HU - Ungheria 2
KR - Corea 2
LU - Lussemburgo 2
NO - Norvegia 2
PK - Pakistan 2
PR - Porto Rico 2
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CH - Svizzera 1
CO - Colombia 1
DK - Danimarca 1
KZ - Kazakistan 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
NP - Nepal 1
PT - Portogallo 1
RS - Serbia 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TH - Thailandia 1
TM - Turkmenistan 1
TW - Taiwan 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 15.118
Salva come PNG Salva come JPEG
Città #
Dublin 1.064
Jacksonville 968
Chandler 885
Singapore 713
Santa Clara 488
Beijing 444
Ashburn 415
Dearborn 403
Nanjing 337
Ann Arbor 332
Boardman 327
Bremen 260
Princeton 259
San Mateo 248
Parma 194
Vienna 154
Toronto 151
Izmir 147
Wilmington 135
Des Moines 118
New York 116
Shanghai 112
Shenyang 112
Helsinki 109
Kunming 94
Hebei 93
Hefei 91
Nanchang 86
Jinan 65
Woodbridge 58
Marseille 53
Grafing 51
Seattle 49
Düsseldorf 45
Brussels 41
Changsha 41
Jiaxing 35
Tianjin 35
Guangzhou 33
Fremont 28
Milan 26
Los Angeles 25
Munich 25
Houston 24
Norwalk 24
Hangzhou 21
Zhengzhou 21
Dallas 16
Reggio Nell'emilia 15
Borås 14
Frankfurt am Main 14
Modena 13
Fuzhou 12
Redwood City 12
Washington 12
Nakano 11
Ottawa 11
Chengdu 10
Haikou 10
Kocaeli 10
Wuhan 10
Abidjan 9
Amsterdam 9
Fairfield 9
Falls Church 9
Verona 9
Auburn Hills 8
Rome 8
Shaoxing 8
Wenzhou 8
Bilbao 7
Edinburgh 7
London 7
Ningbo 7
Pune 7
Redmond 7
Rockville 7
Baotou 6
Cairo 6
Chongqing 6
Florence 6
Neviano degli Arduini 6
Scottsdale 6
Taiyuan 6
Taizhou 6
Xian 6
Catania 5
Istanbul 5
Lanzhou 5
Brno 4
Campi Bisenzio 4
Centro 4
Colli Del Tronto 4
Jakarta 4
Lugo 4
Mestre 4
Mountain View 4
Vicenza 4
Andover 3
Bologna 3
Totale 9.962
Salva come PNG Salva come JPEG
Nome #
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 124
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 124
L’antibiogramma per i miceti 113
Antibacterial effects of two synthetic peptides against Enterococcus faecalis biofilms: A preliminary in vitro study 113
Candidacidal activity of a novel killer toxin from Wickerhamomyces anomalus against fluconazole-susceptible and -resistant strains 108
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 104
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 103
Metabolic profiling of Candida albicans 100
Significato diagnostico delle IgA (secretorie) adese a miceti lievitiformi nel corso delle infezioni orali di pazienti a rischio. 99
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 99
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 97
Antifungal peptides within the antibodies 95
Activity of two antimicrobial peptides against Enterococcus faecalis in a model of biofilm-mediated endodontic infection 95
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 94
Antibodies as a source of anti-infective peptides: an update 93
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 92
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 91
Antimicrobial peptide L18R displays a modulating action against inter-kingdom biofilms in the Lubbock chronic wound biofilm model 88
Antibody peptide based antifungal immunotherapy 87
Antibody-mediated protective immunity in fungal infections 87
A transphyletic anti-infectious control strategy based on the killer phenomenon. 87
A synthetic peptide as a novel anticryptococcal agent 86
Detection of Mycobacterium bovis in bovine tissue samples by the Abbott LCx Mycobacterium tuberculosis assay and comparison with culture methods 86
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BIOFILMS WITH DIFFERENT WAVELENGTHS AND DYES WITH SYNTHETIC KILLER DECAPEPTIDE 86
Fungicidal activity of peptides encoded by immunoglobulin genes 85
Antibiocorpi: anticorpi antiidiotipo ad attività antibiotica e profilattica. 83
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 83
Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model 83
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 82
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 82
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 82
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 82
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 81
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BY DIFFERENT COUPLING OF WAVELENGTHS AND COLORS IN PHOTODYNAMIC PROTOCOLS: IN VITRO AND IN VIVO STUDY 81
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 81
Peptides from the inside of the antibodies are active against infectious agents and tumours 81
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 80
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 80
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 80
Natural and synthetic peptides with antifungal activity 80
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 79
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 77
Antibodies as Crypts of Antiinfective and Antitumor Peptides 76
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities 76
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 76
Wickerhamomyces yeast killer toxins’ medical applications 76
Anaerobic yeast killer system. 75
Antibiobodies: antibiotic internal image antibodies 74
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 74
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 73
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 73
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 72
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 72
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 72
Antifungal activity of the C-terminal peptide from human serum albumin 72
Novel Arginine- and Proline-Rich Candidacidal Peptides Obtained through a Bioinformatic Approach 71
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 71
Nuovo modello di vaccinazione idiotipica e terapia anti-idiotipica nella candidosi sistemica 71
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 71
Metabolic profile of Candida albicans 71
Anticorpi immagini interne di tossine killer 71
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 70
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 70
Immagine interna del fenomeno killer dei lieviti 70
Antireceptor yeast killer toxin-like antibiobodies 70
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 70
Antimicrobial effect on candida albicans biofilm bapplication of different wavelengths and dyes and the synthetic killer decapeptide KP 70
Antibiobodies: antibiotic-like antiidiotypic antibodies. 70
Mode of action of a killer peptide against Toxoplasma gondii 69
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 68
Yeast killer toxins and dimorphism. 67
Marcatori epidemiologici. 67
Any antibody fragment might exert antifungal activity 67
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 67
Mycobacterium parmense sp. nov 66
Principi di micologia generale e tassonomia 66
Valutazione del "Bacto INH Test Strips" per la determinazione della produzione di niacina nei micobatteri. 66
Innate antimicrobial and antiviral activities of antibody peptides 66
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 66
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 66
In silico predicted antifungal peptides: In vitro and in vivo anti-candida activity 66
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 65
Vaccine for the prevention of Aflatoxin B1 carry over in the milk of lactating dairy cows 65
Protective antifungal yeast killer toxin-like antibodies 64
Detection by immunofluorescent anti-idiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans. 64
Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants 64
"Antibiobodies": yeast killer toxin-like anti-idiotypic antibodies 64
Candidacidal properties of peptides encoded by immunoglobulin genes 64
Human natural yeast killer toxin-like antibodies 63
Biotipizzazione di microorganismi patogeni mediante il sistema killer dei lieviti. 63
Production of yeast killer toxin in experimentally infected animals 63
Restriction of Influenza virus multiplication induced by PK peptide treatment 63
Automazione dell’antibiogramma diretto sulle urine. 63
Genomic studies on killer yeasts belonging to the genus Pichia. 63
Idiotypic antifungal vaccination: Immunoprotection by antiidiotypic antibiotic antibodies 63
In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant Gram-positive cocci 62
From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy 62
Allergic bronchopulmonary aspergillosis: An important cause of asthma which is sometimes ignored 62
Relazione struttura-funzione di un peptide fungicida derivato dalla regione costante di immunoglobuline G umane 61
The activity of a mammalian proline-rich peptide against Gram-negative bacteria, including drug-resistant strains, relies on a nonmembranolytic mode of action 61
Totale 7.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.354
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.354
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.565 0 0 0 0 0 295 381 91 246 272 71 209
2020/20211.560 24 212 157 25 241 40 212 22 303 42 226 56
2021/20221.306 31 6 24 59 58 68 169 221 51 128 64 427
2022/20234.045 504 352 216 259 539 456 35 235 1.311 12 92 34
2023/20241.363 79 147 48 55 132 381 59 77 25 90 113 157
2024/20251.867 52 303 317 334 357 504 0 0 0 0 0 0
Totale 15.308